Genmab A (GMAB) Assets Average: 2019-2021
- Genmab A's Assets Average rose 55.39% to $1.2 billion in Q2 2021 from the same period last year, while for Jun 2021 it was $1.2 billion, marking a year-over-year increase of 55.39%. This contributed to the annual value of $2.0 billion for FY2020, which is 59.69% up from last year.
- Latest data reveals that Genmab A reported Assets Average of $1.2 billion as of Q2 2021, which was up 0.00% from $1.2 billion recorded in Q4 2020.
- Genmab A's 5-year Assets Average high stood at $1.3 billion for Q4 2019, and its period low was $780.5 million during Q2 2020.
- Moreover, its 3-year median value for Assets Average was $1.2 billion (2020), whereas its average is $1.1 billion.
- Per our database at Business Quant, Genmab A's Assets Average dropped by 17.25% in 2020 and then skyrocketed by 55.39% in 2021.
- Quarterly analysis of 3 years shows Genmab A's Assets Average stood at $1.3 billion in 2019, then decreased by 3.44% to $1.2 billion in 2020, then spiked by 55.39% to $1.2 billion in 2021.
- Its Assets Average stands at $1.2 billion for Q2 2021, versus $1.2 billion for Q4 2020 and $780.5 million for Q2 2020.
